Marie Wikström Lindholm
Chief Tech/Sci/R&D Officer bij SILENCE THERAPEUTICS PLC
Actieve functies van Marie Wikström Lindholm
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
SILENCE THERAPEUTICS PLC | Chief Tech/Sci/R&D Officer | 01-12-2023 | - |
Corporate Officer/Principal | 02-11-2020 | 01-12-2023 | |
Oligonucleotide Therapeutics Society, Inc.
Oligonucleotide Therapeutics Society, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Beckman Research Institute of The City of Hope, Oligonucleotide Therapeutics Society, Inc. is a society that envisions a new era of oligonucleotide drugs that would change the landscape of therapeutic modalities. The private company is based in San Diego, CA. Over 100 treatments are in development for common conditions, including cancer and Alzheimer’s disease, as well as rare diseases. The society offers various awards to support the accomplishments of students, postdocs, and young investigators. | Director/Board Member | 18-01-2022 | - |
Loopbaan van Marie Wikström Lindholm
Eerdere bekende functies van Marie Wikström Lindholm
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
University of Lund | Corporate Officer/Principal | 01-01-1999 | 01-01-2000 |
Opleiding van Marie Wikström Lindholm
University of Uppsala | Doctorate Degree |
Statistieken
Internationaal
Zweden | 3 |
Verenigd Koninkrijk | 2 |
Verenigde Staten | 2 |
Operationeel
Corporate Officer/Principal | 2 |
Chief Tech/Sci/R&D Officer | 1 |
Doctorate Degree | 1 |
Sectoraal
Commercial Services | 3 |
Consumer Services | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
SILENCE THERAPEUTICS PLC | Commercial Services |
Bedrijven in privébezit | 1 |
---|---|
Oligonucleotide Therapeutics Society, Inc.
Oligonucleotide Therapeutics Society, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Beckman Research Institute of The City of Hope, Oligonucleotide Therapeutics Society, Inc. is a society that envisions a new era of oligonucleotide drugs that would change the landscape of therapeutic modalities. The private company is based in San Diego, CA. Over 100 treatments are in development for common conditions, including cancer and Alzheimer’s disease, as well as rare diseases. The society offers various awards to support the accomplishments of students, postdocs, and young investigators. | Commercial Services |